Anfield Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,158
| Closed | -$40.1K | – | 73 |
|
|
2022
Q4 | $40.1K | Sell |
2,158
-1,920
| -47% | -$35.7K | 0.02% | 75 |
|
|
2022
Q3 | $52K | Buy |
4,078
+95
| +2% | +$1.21K | 0.02% | 81 |
|
|
2022
Q2 | $28K | Buy |
3,983
+380
| +11% | +$2.67K | 0.01% | 85 |
|
|
2022
Q1 | $30K | Buy |
3,603
+2,010
| +126% | +$16.7K | 0.01% | 85 |
|
|
2021
Q4 | $11K | Buy |
1,593
+1,468
| +1,174% | +$10.1K | ﹤0.01% | 90 |
|
|
2021
Q3 | $1K | Buy |
+125
| New | +$1K | ﹤0.01% | 108 |
|